François-Xavier Roger, incoming Sanofi CFO
February 1, 2024 06:33 AM ESTUpdated 08:16 AM
R&D
Pharma

‘Watch this evolve’: Sanofi con­tin­ues to talk up its R&D bet as Paul Hud­son wel­comes new CFO

Amber Tong

As Sanofi CEO Paul Hud­son em­barks on a two-year mis­sion to cut and re­al­lo­cate up to €2 bil­lion ($2.16 bil­lion) in costs, he will be …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

As­traZeneca’s Truqap edges clos­er to prostate can­cer la­bel ex­pan­sion with Phase 3 win

A service from the Financial Times